Coeptis Therapeutics Holdings, Inc. Warrants
COEPW
COEPW: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio comprises multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
moreShow COEPW Financials
Recent trades of COEPW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by COEPW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on COEPW's company Twitter account
Number of mentions of COEPW in WallStreetBets Daily Discussion
Recent insights relating to COEPW
Recent picks made for COEPW stock on CNBC
ETFs with the largest estimated holdings in COEPW
Flights by private jets registered to COEPW